+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Active Implantable Medical Devices Market - Global Forecast 2026-2032- Product Image
Active Implantable Medical Devices Market - Global Forecast 2026-2032- Product Image
New

Active Implantable Medical Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905106
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The active implantable medical devices market is transforming as digital health adoption, regulatory complexity, and emerging clinical needs push leaders to align innovation with operational strength. Forward-looking organizations recognize the need to balance clinical outcomes, future-ready strategies, and efficient deployment across diverse care environments.

Market Snapshot: Active Implantable Medical Devices Market

The Active Implantable Medical Devices Market recorded growth from USD 3.21 billion in 2025 to USD 3.55 billion in 2026 and is projected to reach USD 6.73 billion by 2032, reflecting a CAGR of 11.14%. Market momentum stems from advances in power management and miniaturization, driving the evolution of integrated device platforms. This convergence enables manufacturers to deliver superior therapeutic impact while deepening device connectivity, meeting the varied needs of a growing patient population. Clinical efficacy combines with flexible operations as organizations pursue business models that anticipate and address shifting healthcare demands.

Scope & Segmentation of the Active Implantable Medical Devices Market

  • Device Types: Cardiac pacemakers, cochlear implants, implantable cardioverter defibrillators, infusion pumps, and neurostimulators each support complex clinical scenarios, ranging from cardiology to neurology and ear care. Distinct design criteria and unique patient monitoring requirements drive differentiated therapeutic approaches across these core devices.
  • Technology: Non-rechargeable and rechargeable formats, advanced sensing, stimulation capabilities, and integrated drug delivery, along with digital telemetry, all contribute to the dynamic feature landscape. Digital telemetry enhances remote monitoring, enabling a higher level of patient-provider interaction.
  • Patient Demographics: Adults, geriatric patients, and pediatric segments each bring specific clinical and operational challenges, influencing aspects such as device selection, performance lifespan, and ongoing care plans. This customization is essential for meeting clinical objectives and growing market access.
  • Clinical Applications: Devices enable solutions for cardiac rhythm management, endocrine therapies, neurological interventions, and otological needs. Manufacturers and clinicians must adjust to variable therapy protocols and ensure smooth integration with diverse health systems.
  • Care Settings: Ambulatory surgical centers, clinics, as well as private and public hospitals, all play crucial roles in device deployment. The structure of each setting shapes procurement cycles, post-implantation support, and product adoption rates.
  • Regional Focus: Distinct geography-based factors across the Americas, Europe Middle East & Africa, and Asia-Pacific influence reimbursement structures, regulatory approvals, and health system requirements. These elements require tailored strategies to optimize market entry and local adoption.

Each axis of segmentation demonstrates the centrality of fit-for-purpose innovation and process design. Patient age and clinical context steer device durability and form, while local regulatory and reimbursement frameworks present key considerations for commercial strategy. Adoption of telehealth and advanced features further impacts workflow and standardization, making nuanced market understanding essential for sustained value creation.

Key Takeaways for Senior Decision-Makers

  • Miniaturized devices with advanced power systems are expanding connectivity, empowering organizations to implement scalable remote monitoring and proactive management capabilities across patient cohorts.
  • Enhanced digital functionality, such as real-time telemetry and remote titration, is redefining care delivery, necessitating robust data management and cybersecurity frameworks to protect sensitive health information.
  • Intense competition is prompting both prominent industry leaders and niche innovators to accelerate adaptive product development, validate real-world performance, and capture differentiated market positioning.
  • Business models prioritizing bundled care and outcome-based contracts enable payers and providers to seek solutions delivering sustained patient value, forging new pathways for supplier collaboration and evidence-based decision-making.
  • Variation in demographics, clinical use, and healthcare setting mandates tailored device development and precise commercial planning to ensure relevance and effective market penetration.

Tariff Impact on Supply Chain & Procurement

Evolving United States tariff policies drive continuous revisions in manufacturer procurement and supply strategies within the active implantable medical devices market. Companies have safeguarded supply by diversifying sourcing, expanding nearshore production, and refining footprint flexibility. Standard practice includes renegotiating supplier contracts, optimizing inventory levels, and focusing on comprehensive landed cost evaluation. Strategic scenario planning remains essential, ensuring uninterrupted product delivery to healthcare settings despite fluctuating trade conditions.

Methodology & Data Sources

This report synthesizes rigorous literature reviews, direct expert interviews, and observational studies. The analytical process covers technical, clinical, and commercial dimensions, including device evaluation, assessment of regulatory submissions, and supply chain documentation. Integration of findings through triangulation delivers balanced, actionable insights for informed executive planning.

Why This Report Matters

  • Supports benchmarking of key trends—technological, regulatory, and service-related—providing an evidence-based foundation for executive decisions in the active implantable medical devices market.
  • Clarifies market segmentation drivers, supply chain vulnerabilities, and competitive differentiation, enabling senior leadership to shape global investment and operational roadmaps.
  • Facilitates strategic planning around evidence documentation, service model evolution, and risk management aligned to dynamic payer and provider demands.

Conclusion

Aligning clinical advances with robust operational execution remains essential for stakeholders in the active implantable medical devices sector. This report equips decision-makers to drive resilience, scalability, and patient-centered value amid continued industry transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Active Implantable Medical Devices Market, by Device Type
8.1. Cardiac Pacemaker
8.2. Cochlear Implant
8.3. Implantable Cardioverter Defibrillator
8.4. Infusion Pump
8.5. Neurostimulator
9. Active Implantable Medical Devices Market, by Technology
9.1. Non-Rechargeable
9.2. Rechargeable
10. Active Implantable Medical Devices Market, by Patient Age Group
10.1. Adult
10.2. Geriatric
10.3. Pediatric
11. Active Implantable Medical Devices Market, by Application
11.1. Cardiology
11.1.1. Heart Failure Management
11.1.2. Heart Rhythm Management
11.2. Endocrinology
11.3. Neurology
11.3.1. Deep Brain Stimulation
11.3.2. Spinal Cord Stimulation
11.4. Otology
12. Active Implantable Medical Devices Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Clinics
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
13. Active Implantable Medical Devices Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Active Implantable Medical Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Active Implantable Medical Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Active Implantable Medical Devices Market
17. China Active Implantable Medical Devices Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Advanced Bionics Corporation
18.7. Aleva Neurotherapeutics S.A.
18.8. Axonics Modulation Technologies, Inc.
18.9. Berlin Heart GmbH
18.10. BIOTRONIK SE & Co. KG
18.11. Boston Scientific Corporation
18.12. Calon Cardio Ltd.
18.13. CARMAT SA
18.14. Cochlear Limited
18.15. CVRx Inc.
18.16. Envoy Medical Corporation
18.17. Inspire Medical Systems, Inc.
18.18. Jarvik Heart, Inc.
18.19. LivaNova PLC
18.20. Medtronic plc
18.21. MED-EL Elektromedizinische Geräte GmbH
18.22. MicroPort CRM Corporation
18.23. MicroTransponder Inc.
18.24. Nevro Corp.
18.25. Nurotron Biotechnology Co., Ltd.
18.26. Oticon Medical A/S
18.27. Sonova Holding AG
18.28. SynCardia Systems LLC
18.29. William Demant Holding A/S
List of Figures
FIGURE 1. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIAC PACEMAKER, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIAC PACEMAKER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIAC PACEMAKER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COCHLEAR IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COCHLEAR IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COCHLEAR IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NON-RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NON-RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NON-RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HEART RHYTHM MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HEART RHYTHM MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HEART RHYTHM MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY OTOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY OTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY OTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 120. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 134. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 136. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 141. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 159. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 162. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 164. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 166. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 168. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 169. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 180. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 182. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 184. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 186. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 187. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 189. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 191. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 193. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 195. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 196. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 198. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 200. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 202. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 204. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 205. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 217. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 219. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 220. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 221. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 223. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 224. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Active Implantable Medical Devices market report include:
  • Abbott Laboratories
  • Advanced Bionics Corporation
  • Aleva Neurotherapeutics S.A.
  • Axonics Modulation Technologies, Inc.
  • Berlin Heart GmbH
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Calon Cardio Ltd.
  • CARMAT SA
  • Cochlear Limited
  • CVRx Inc.
  • Envoy Medical Corporation
  • Inspire Medical Systems, Inc.
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MED-EL Elektromedizinische Geräte GmbH
  • MicroPort CRM Corporation
  • MicroTransponder Inc.
  • Nevro Corp.
  • Nurotron Biotechnology Co., Ltd.
  • Oticon Medical A/S
  • Sonova Holding AG
  • SynCardia Systems LLC
  • William Demant Holding A/S

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.55 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.73 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Active Implantable Medical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Active Implantable Medical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Implantable Medical Device Market - Global Forecast 2026-2032 - Product Image

Implantable Medical Device Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Active Implantable Medical Device Motor Market - Global Forecast 2025-2030 - Product Image

Active Implantable Medical Device Motor Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Implantable Medical Devices - Global Strategic Business Report - Product Image

Implantable Medical Devices - Global Strategic Business Report

  • Report
  • 244 Pages
  • Global
From
Active Implantable Medical Devices - Global Strategic Business Report - Product Image

Active Implantable Medical Devices - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From

About the Active Implantable Medical Device Market

The Active Implantable Medical Device (AIMD) market is a subset of the medical device industry that focuses on the development and production of medical devices that are implanted into the body. These devices are designed to monitor, diagnose, and treat a variety of medical conditions. AIMDs are typically powered by batteries and are designed to be implanted for long-term use. Examples of AIMDs include pacemakers, implantable cardioverter defibrillators, neurostimulators, and drug delivery systems. AIMDs are regulated by the Food and Drug Administration (FDA) and must meet stringent safety and efficacy standards. The market is highly competitive, with a number of large companies competing for market share. Some of the major players in the AIMD market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Biotronik. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.